Helius Medical Technologies Inc (NASDAQ:HSDT) traded at $0.36 at close of the session on Friday, June 20 and made an upward move of 0.33% on its previous day’s price.
Looking at the stock we see that its previous close was $60.00 and the beta (5Y monthly) reads 1.13 with the day’s price range being $0.322 – $0.36. In terms of its 52-week price range, HSDT has a high of $24.00 and a low of $0.30. The company’s stock has lost about -92.81% over that past 30 days.
Helius Medical Technologies Inc has a market cap of $0.17 million and is expected to release its quarterly earnings report on 2025-May-01.
Based on estimates by 3 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Helius Medical Technologies Inc (HSDT) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 21 off its SMA20 and 0.00 from its 50-day simple moving average. The beta value is -99.97%, while the average true range (ATR) is currently pointing at -100.00%.
Coming back to Helius Medical Technologies Inc (NASDAQ:HSDT), we note that the average 3-month trading volume was 1.45, while that of the preceding 10-day period stands at 32.31 million. Current shares outstanding are 0.53 million.
The insiders hold 5.46% of the company’s shares while institutions hold 77.83%. The data shows that short shares as of 2025-05-30, stood at 62031.0 at a short ratio of 1.98. This represents a 1175.00 short interest in shares outstanding on 2025-05-30. Shares short rose in May from the previous month at 1414.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -97.86% down in year-to-date price movement.
